B cells can capture tumor antigens and activate immune cells in the initial stage of the immune response, or participate in tumor killing by secreting antibodies, such as CCL2, CXCR4, CCL5, CXCL5 and CXCL10, which trigger the activation of CD4 and CD8 T cells [49]. The gene discussed is CCL5; the disease is neoplasm.